STAT1 and chronic mucocutaneous candidiasis: Bloomfield Bloomfield M M Kanderová Kanderová V V Paracková Paracková Z Z Vrabcová Vrabcová P P Svatoñ Svatoñ M M Froňková Froňková E E Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation J Clin Immunol J Clin Immunol 2018 2018 38 38 589 589 601 601 10.1007/s10875-018-0519-6 10.1007/s10875-018-0519-6 29934865 29934865